Absence of immunoglobulin class switch in primary lymphomas of the central nervous system

American Journal of Pathology

Volumn 166, Issue 6, 2005, Pages 1773-1779

  Montesinos Rongen, Manuel ^a   Schmitz, Roland ^b   Courts, Cornelius ^a   Stenzel, Werner ^a   Bechtel, Dörte ^b   Niedobitek, Gerald ^c   Blümcke, Ingmar ^c   Reifenberger, Guido ^d   Von Deimling, Andreas ^e   Jungnickel, Berit ^f   Wiestler, Otmar D ^g   Küppers, Ralf ^b   Deckert, Martina ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; FEMALE; GENE REARRANGEMENT; GENE SWITCHING; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN GENE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 21144453103     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62487-X     Document Type: Article

References (27)

1. DeAngelis LM: Primary central nervous system lymphomas. Curr Treat Options Oncol 2001, 2:309-318
2. Gatter KC, Warnke RA: Diffuse Large Cell Lymphoma. Edited by ES Jaffe, NL Harris, H Stein, JW Vardiman. Lyon, IARC Press, 2001, pp 171-174
3. Schlegel U, Schmidt-Wolf IG, Deckert M: Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci 2000, 181:1-12
4. Montesinos-Rongen M, Küppers R, Schlüter D, Spieker T, Van Roost D, Schaller C, Reifenberger G, Wiestler OD, Deckert-Schlüter M: Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol 1999, 155:2077-2086
5. Thompsett AR, Ellison DW, Stevenson FK, Zhu D: V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. Blood 1999, 94:1738-1746
6. Klein U, Rajewsky K, Küppers R: Human immunoglobulin (Ig)M +IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: cD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998, 188:1679-1689
7. Klein U, Goossens T, Fischer M, Kanzler H, Braeuninger A, Rajewsky K, Küppers R: Somatic hypermutation in normal and transformed human B cells. Immunol Rev 1998, 162:261-280
8. Montesinos-Rongen M, Van Roost D, Schaller C, Wiestler OD, Deckert M: Primary diffuse large B cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood 2004, 103:1869-1875
9. Manis JP, Tian M, Alt FW: Mechanism and control of class-switch recombination. Trends Immunol 2002, 23:31-39
10. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T: Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563
11. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO, Honjo T: Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999, 274:18470-18476
12. Honjo T, Kinoshita K, Muramatsu M: Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol 2002, 20:165-196
13. Smit LA, Bende RJ, Aten J, Guikema JE, Aarts WM, van Noesel CJ: Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res 2003, 63:3894-3898
14. Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, Castle BE, Janda J, Marcu KB, Parwaresch R: Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 2003, 101:3574-3580
15. Greiner A, Tobollik S, Buettner M, Jungnickel B, Herrmann K, Kremmer E, Niedobitek G: Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte predominant and classical Hodgkin lymphoma. J Pathol 2005, 205:541-547
16. Lefranc MP: IMGT databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis, http://imgt.cines.fr. Leukemia 2003, 17:260-266
17. Zhang K, Cheah HK, Saxon A: Secondary deletional recombination of rearranged switch region in Ig isotype-switched B cells: a mechanism for isotype stabilization. J Immunol 1995, 154:2237-2247
18. Pasqualucci L, Guglielmino R, Houldsworth J, Mohr J, Aoufouchi S, Polakiewicz R, Chaganti RS, Dalla-Favera R: Expression of the AID protein in normal and neoplastic B cells. Blood 2004, 104:3318-3325
19. Vaandrager JW, Schuuring E, Kluin-Nelemans HC, Dyer MJ, Raap AK, Kluin PM: DNA fiber fluorescence in situ hybridization analysis of immunoglobulin class switching in B-cell neoplasia: aberrant CH gene rearrangements in follicle center-cell lymphoma. Blood 1998, 92:2871-2878
20. Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY: IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 1998, 160:3555-3561
21. Cerutti A, Zan H, Schaffer A, Bergsagel L, Harindranath N, Max EE, Casali P: CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line. J Immunol 1998, 160:2145-2157
22. Zan H, Cerutti A, Dramitinos P, Schaffer A, Casali P: CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-beta: evidence for TGF-beta but not IL-10-dependent direct S mu→S alpha and sequential S mu→S gamma, S gamma→S alpha DNA recombination. J Immunol 1998, 161:5217-5225
23. Fujieda S, Saxon A, Zhang K: Direct evidence that gamma 1 and gamma 3 switching in human B cells is interleukin-10 dependent. Mol Immunol 1996, 33:1335-1343
24. Schlüter D, Kaefer N, Hof H, Wiestler OD, Deckert-Schlüter M: Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am J Pathol 1997, 150:1021-1035
25. Klein U, Küppers R, Rajewsky K: Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood 1997, 89:1288-1298
26. Nardini E, Rizzi S, Capello D, Vitolo U, Gaidano G, Menard S, Balsari A: Most immunoglobulin heavy chain switch mu rearrangements in B-cell chronic lymphocytic leukemia are internal deletions. FEBS Lett 2002, 518:119-123
27. Montesinos-Rongen M, Zühlke-Jenisch R, Gesk S, Martin-Subero JI, Schaller C, Van Roost D, Wiestler OD, Deckert M, Siebert R: Interphase cytogenetic analysis of lymphoma-associated chromosomal breakpoints in primary diffuse large B-cell lymphomas of the central nervous system. J Neuropathol Exp Neurol 2002, 61:926-933